2016
DOI: 10.1124/pr.116.012518
|View full text |Cite
|
Sign up to set email alerts
|

Kinases as Novel Therapeutic Targets in Asthma and Chronic Obstructive Pulmonary Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
81
0

Year Published

2017
2017
2021
2021

Publication Types

Select...
6
2
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 98 publications
(82 citation statements)
references
References 331 publications
(305 reference statements)
1
81
0
Order By: Relevance
“…The oxidative stress inhibits the protein levels of PTEN in patients with COPD, which results in the persistent activation of the PI3K/Akt pathway and resultant proin-flammatory mediator release. In addition, activation of PI3K signaling, decreased PTEN expression may also be important in corticosteroid resistance and accelerated aging, as well as the increased risk of lung cancer in COPD (Barnes 2016). Crosstalk analysis of significantly enriched pathways obtained two mainly pathway clusters that closely associated with immune and signal transduction respectively, this should be an important clue for studying COPD progression.…”
Section: Discussionmentioning
confidence: 86%
“…The oxidative stress inhibits the protein levels of PTEN in patients with COPD, which results in the persistent activation of the PI3K/Akt pathway and resultant proin-flammatory mediator release. In addition, activation of PI3K signaling, decreased PTEN expression may also be important in corticosteroid resistance and accelerated aging, as well as the increased risk of lung cancer in COPD (Barnes 2016). Crosstalk analysis of significantly enriched pathways obtained two mainly pathway clusters that closely associated with immune and signal transduction respectively, this should be an important clue for studying COPD progression.…”
Section: Discussionmentioning
confidence: 86%
“…The JAK / STAT pathway has been suggested as an asthma target through inhibitors of activating cytokines and receptors (Vale, 2016, Weltman and Karim, 1998). JAK pathway inhibitors are in development for a number of inflammatory disorders (O’Shea et al, 2015), and animal models have suggested that targeting this pathway can reduce airway hyperresponsiveness, reflecting the potential for such compounds in both COPD and asthma (Barnes, 2016). The role for JAK / STAT signaling in bronchopulmonary dysplasia is less clear, but it has been suggested that it plays a role in airway smooth muscle mitogenesis, implicated in both asthma and BPD (Simon et al, 2002), and postulated that it may be an alternative mediator of the oxidative stress response in both diseases (Zhou and Hershenson, 2003).…”
Section: Resultsmentioning
confidence: 99%
“…Our study shows that NE increases integrin-mediated adhesion of M□ and modulate cytokine release from M□ through Src activation since Src kinase inhibitor PP2 inhibited the increase in cytokine expression. Recently, activated Hck (hematopoietic cell kinase), a myeloid-specific Src family kinase, was implied in lung –associated diseases (56,57). It has been shown that mice with a constitutively active Hck mutant develop in the lungs areas of mild emphysema and fibrosis (58).…”
Section: Discussionmentioning
confidence: 99%